SOC 2, HITRUST, and BAAs should be treated as starting points, not trust signals. They tell you what a vendor claims about its controls. They do not tell you whether those controls are actually working today or whether the evidence behind the attestation was real. The post Healthcare’s Assurance Infrastructure Is Broken. The Compliance Industry Built It That Way appeared first on MedCity News .
The true promise of AI lies not in autonomy of either the clinician or machine, but in a balanced collaboration that bolsters the strengths of each. The post Bridging Movement and Machine Learning: How Clinicians Can Harness AI in Practice appeared first on MedCity News .
It’s not hard to understand why patients turn to social media for GLP-1 guidance. The healthcare system leaves a huge gap between getting a prescription and actually understanding how to use it well. The post GLP-1s Are a $70 Billion Market — So Why Are Patients Still Getting Medical Advice From TikTok Influencers? appeared first on MedCity News .
The research is clear: Among the various complex issues that contribute to suicide, loneliness is a big one. Now, there’s a growing push to address loneliness not just through personal choices but also through public policy.
Anxious kids can benefit from counseling, but therapy demands a commitment of money and time. Therapists recommend using three criteria to help determine when challenging behavior rises to the level of needing professional help.
Healthcare affordability czar Casey Mulligan laid out the economic philosophy guiding the Trump administration’s approach to healthcare costs during a recent conference address. He argued that provider taxes and state-directed payments inflate healthcare spending far beyond Medicaid and ultimately raise costs for employers and taxpayers. The post HHS Affordability Czar Says Healthcare Costs Stem From Incentives, Not Coverage appeared first on MedCity News .
Incyte’s Vega Therapeutics acquisition comes with a late-stage drug offering a novel mechanism of action and a dosing advantage compared to currently available therapies for von Willebrand disease, an inherited bleeding disorder. The deal comes as patent expiration looms for Jakafi, currently Incyte’s top product. The post Incyte’s $1.25B Buyout Brings What Could Become the Next Big Bleeding Disorder Drug appeared first on MedCity News .
Vida Health partnered with Instacart to provide members with grocery stipends for healthy foods, expanding access to nutrition support as part of cardiometabolic care. The post Vida Health Teams Up with Instacart to Expand Access to Nutritious Food appeared first on MedCity News .
By fine-tuning domain-specific models with real clinical operations data — such as historical performance, feasibility outcomes, enrollment patterns, and resource utilization — hidden information can be translated into structured intelligence. The post How AI is Unlocking Smarter Clinical Trial Protocols appeared first on MedCity News .
Supply chain resilience is far too important to leave with the supply chain specialists. Health systems must elevate the resilience issue to the corporate strategy level and involve officers from other functional areas as well. The post 6 Ways in Which Healthcare Needs to Expand the Supply Chain Resilience Conversation appeared first on MedCity News .
While the policy changes create new opportunities, they also introduce operational complexity. Here’s some important things to know. The post Expanding the Reach of Remote Patient Monitoring: The Real Signal Behind the 2026 RPM Changes appeared first on MedCity News .
Health secretary Robert F. Kennedy Jr.’s new autism panel is championing a controversial communication method popular among parents of severely autistic people. Critics warn of abuse — and fake “telepathy.”